Literature DB >> 11994471

Identification of a novel Ly49 promoter that is active in bone marrow and fetal thymus.

Ali Saleh1, Andrew P Makrigiannis, Deborah L Hodge, Stephen K Anderson.   

Abstract

The analysis of several Ly49 genes has identified a tissue-specific promoter adjacent to the previously defined first exon. The current study reveals the presence of an additional Ly49 promoter (Pro-1) and two noncoding exons upstream of the previously defined promoter (Pro-2). DNA sequences homologous to Pro-1 are present 4-10 kb upstream of Pro-2 in all Ly49 genes examined, and Pro-1 transcripts were detected from the Ly49a, e, g, o, and v genes. Pro-1 activity can be detected in bone marrow, embryonic thymus, freshly isolated liver NK cells, and the murine LNK cell line, but it does not function in adult thymus, sorted NK-T cells, spleen NK cells, or the EL-4 T cell line, even though these cells express Ly49 proteins. Luciferase reporter assays identified a Pro-1 core promoter region that functions in the LNK cell line but not EL-4 cells. The novel promoter is not active in mature NK cells, suggesting that Pro-1 represents an early Ly49 promoter.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11994471     DOI: 10.4049/jimmunol.168.10.5163

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  18 in total

Review 1.  NKR-P1 biology: from prototype to missing self.

Authors:  Aruz Mesci; Belma Ljutic; Andrew P Makrigiannis; James R Carlyle
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

2.  Mouse Ly49G2+ NK cells dominate early responses during both immune reconstitution and activation independently of MHC.

Authors:  Isabel Barao; Maite Alvarez; Erik Ames; Mark T Orr; Heather E Stefanski; Bruce R Blazar; Lewis L Lanier; Stephen K Anderson; Doug Redelman; William J Murphy
Journal:  Blood       Date:  2011-04-15       Impact factor: 22.113

Review 3.  Killer immunoglobulin-like receptor transcriptional regulation: a fascinating dance of multiple promoters.

Authors:  Frank Cichocki; Jeffrey S Miller; Stephen K Anderson
Journal:  J Innate Immun       Date:  2011-03-11       Impact factor: 7.349

4.  Binary outcomes of enhancer activity underlie stable random monoallelic expression.

Authors:  Djem U Kissiov; Alexander Ethell; Sean Chen; Natalie K Wolf; Chenyu Zhang; Susanna M Dang; Yeara Jo; Katrine N Madsen; Ishan Paranjpe; Angus Y Lee; Bryan Chim; Stefan A Muljo; David H Raulet
Journal:  Elife       Date:  2022-05-26       Impact factor: 8.713

5.  Transcriptional control of human antigen R by bone morphogenetic protein.

Authors:  Selvi C Jeyaraj; Mamata Singh; Dina A Ayupova; Suman Govindaraju; Beth S Lee
Journal:  J Biol Chem       Date:  2009-12-14       Impact factor: 5.157

6.  The transcription factor c-Myc enhances KIR gene transcription through direct binding to an upstream distal promoter element.

Authors:  Frank Cichocki; Rebecca J Hanson; Todd Lenvik; Michelle Pitt; Valarie McCullar; Hongchuan Li; Stephen K Anderson; Jeffrey S Miller
Journal:  Blood       Date:  2008-11-05       Impact factor: 22.113

7.  Ly49 cluster sequence analysis in a mouse model of diabetes: an expanded repertoire of activating receptors in the NOD genome.

Authors:  S Belanger; L-H Tai; S K Anderson; A P Makrigiannis
Journal:  Genes Immun       Date:  2008-06-05       Impact factor: 2.676

8.  The distal upstream promoter in Ly49 genes, Pro1, is active in mature NK cells and T cells, does not require TATA boxes, and displays enhancer activity.

Authors:  Frances Gays; Sally Taha; Colin G Brooks
Journal:  J Immunol       Date:  2015-04-29       Impact factor: 5.422

9.  Comprehensive analysis of transcript start sites in ly49 genes reveals an unexpected relationship with gene function and a lack of upstream promoters.

Authors:  Frances Gays; Alan S C Koh; Katarzyna M Mickiewicz; Jonathan G Aust; Colin G Brooks
Journal:  PLoS One       Date:  2011-03-31       Impact factor: 3.240

10.  Evidence for high bi-allelic expression of activating Ly49 receptors.

Authors:  Arefeh Rouhi; C Benjamin Lai; Tammy P Cheng; Fumio Takei; Wayne M Yokoyama; Dixie L Mager
Journal:  Nucleic Acids Res       Date:  2009-07-15       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.